Skip to content
Screener

BioLife Solutions BLFS Shares (Diluted)

Shares (Diluted) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
371M-1.9%
Danaher logo
DanaherDHR
707.6M-1.6%
Azenta logo
AzentaAZTA
45.3M-1.1%
TEC
Bio-TechneTECH
157.4M-1.0%
Revvity logo
RevvityRVTY
111.9M-7.0%
CryoPort, Inc. logo
CryoPort, Inc.CYRX
50.4M+0.4%

Other financials

Income statement

See full
Revenue$28.5M+21.5%
Gross profit$18.3M+20.0%
Operating income$1.7M+111%
Net income$45.1M+385%
EPS (diluted)$0.91+376%

Balance sheet

See full
Cash & equivalents$24.0M-24.8%
Total debt$15.7M-33.9%
Total equity$420.0M+21.0%
Total assets$447.5M+15.6%

Cash flow

See full
Operating cash flow$6.3M-13.8%
CapEx$1.0M-40.2%
Free cash flow$5.3M-5.7%

Valuation

See full
Market cap$1.7B+56.2%
Enterprise value$1.69B+56.7%
P/E54.6×
P/S16.5×+3.3×

Profitability

See full
Gross margin67.2%
Operating margin1.6%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio9.7×+5.3×

Where this comes from

Reported directly by BioLife Solutions in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:22 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-054355
(In thousands, except per share and share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Net income (loss) per share$0.92$(0.33)$0.95$(0.34)
Net income (loss) per share - Diluted:
Continuing operations$0.91$(0.32)$0.94$(0.31)
Discontinued operations$(0.01)$(0.03)
Net income per share$0.91$(0.33)$0.94$(0.34)
Weighted average shares used to compute income (loss) per share:
Basic48,866,82247,798,14648,663,80747,468,266
Diluted49,294,67947,798,14649,259,52847,468,266

Item 1. Unaudited Condensed Consolidated Financial Statements

FAQ

What is BioLife Solutions's shares (diluted)?
BioLife Solutions (BLFS) reported shares (diluted) of 49.3M in Q2 2026.
How has BioLife Solutions's shares (diluted) changed year-over-year?
BioLife Solutions's shares (diluted) increased by 3.1% year-over-year, from 47.8M to 49.3M.
What is the long-term trend for BioLife Solutions's shares (diluted)?
Over 3 years (2021 to 2025), BioLife Solutions's shares (diluted) has grown at a 7.6% compound annual growth rate (CAGR), from 155.4M to 193.5M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about BioLife Solutions's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude